共 50 条
- [33] BIOLOGICAL FEATURES OF MYELODYSPLASTIC SYNDROMES (MDS) PREDICTS FOR SURVIVAL AND THERAPY RESPONSE MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 155 - 170
- [35] Cytogenetic changes in myelodysplastic syndromes (MDS) CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 71 - 71
- [38] Molecular and Diagnostic Testing Patterns in Elderly Patients with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S315 - S315
- [39] Case report - Use of iron chelate therapy for patients with myelodysplastic Syndromes (MDS) ONKOLOGIE, 2007, 30 (10): : 525 - 525
- [40] Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS) Cancer Causes & Control, 2021, 32 : 241 - 250